We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

130 hedge funds and large institutions have $243M invested in Vaxart in 2020 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 18

79% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 19

48% more funds holding

Funds holding: 88130 (+42)

43% more call options, than puts

Call options by funds: $14.5M | Put options by funds: $10.1M

40% more capital invested

Capital invested by funds: $173M → $243M (+$69.3M)

7.28% more ownership

Funds ownership: 26.42%33.7% (+7.3%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
130
Holders Change
+42
Holders Change %
+47.73%
% of All Funds
2.62%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
60
Increased
34
Reduced
19
Closed
18
Calls
$14.5M
Puts
$10.1M
Net Calls
+$4.34M
Net Calls Change
+$4.34M
Name Holding Trade Value Shares
Change
Change in
Stake
AIG
51
American International Group
New York
$208K +$36.5K +4,095 +15%
Manulife (Manufacturers Life Insurance)
52
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$201K +$26.8K +3,005 +11%
OSAM
53
O'Shaughnessy Asset Management
Connecticut
$182K +$243K +27,306 New
Allianz Asset Management
54
Allianz Asset Management
Germany
$182K +$244K +27,443 New
ECM
55
ExodusPoint Capital Management
New York
$169K +$226K +25,405 New
Bank of America
56
Bank of America
North Carolina
$153K -$163K -18,259 -44%
MIM
57
MetLife Investment Management
New Jersey
$148K
CG
58
Cutler Group
California
$148K +$199K +22,288 New
Cambridge Investment Research Advisors
59
Cambridge Investment Research Advisors
Iowa
$135K -$75.4K -8,468 -29%
JP Morgan Chase
60
JP Morgan Chase
New York
$133K -$156K -17,546 -47%
EDRH
61
Edmond de Rothschild Holding
Switzerland
$133K
Osaic Holdings
62
Osaic Holdings
Arizona
$128K +$144K +16,120 +522%
PPP
63
Private Portfolio Partners
New Jersey
$124K +$167K +18,700 New
JWCA
64
J.W. Cole Advisors
Florida
$123K +$165K +18,500 New
State Board of Administration of Florida Retirement System
65
State Board of Administration of Florida Retirement System
Florida
$122K
CS
66
Credit Suisse
Switzerland
$122K +$164K +18,377 New
VOYA Investment Management
67
VOYA Investment Management
Georgia
$118K +$23.8K +2,677 +18%
Victory Capital Management
68
Victory Capital Management
Texas
$112K +$43.3K +4,865 +41%
MLICM
69
Metropolitan Life Insurance Company (MetLife)
New York
$104K +$1.98K +222 +1%
Citigroup
70
Citigroup
New York
$93K +$70.7K +7,938 +132%
Creative Planning
71
Creative Planning
Kansas
$90K +$121K +13,540 New
Bank of Montreal
72
Bank of Montreal
Ontario, Canada
$89K +$50.2K +5,642 +74%
PPA
73
Parametric Portfolio Associates
Washington
$84K +$113K +12,669 New
HighTower Advisors
74
HighTower Advisors
Illinois
$83K +$110K +12,297 New
BNP Paribas Financial Markets
75
BNP Paribas Financial Markets
France
$81.7K +$94.5K +10,613 +636%

VXRT Hedge Fund Activity: Q3 2020 in Review

130 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q3 2020, worth a combined $243M — up 40% from $173M a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new VXRT positions and 18 closed out — a net gain of 42 holders — while 34 added to existing stakes and 19 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $96.3M. The largest seller was Citadel Advisors, cutting an estimated $25.6M.

  • 130 institutional investors held Vaxart (VXRT) as of Q3 2020, up from 88 in Q2 2020.
  • Funds reported $243M of Vaxart stock for Q3 2020, up 40% quarter-over-quarter.
  • 60 funds opened new Vaxart positions in Q3 2020 and 18 closed out, a net change of +42 holders.
  • The largest Vaxart buyer in Q3 2020 was RA Capital Management, an estimated $96.3M added.
  • The largest Vaxart seller in Q3 2020 was Citadel Advisors, an estimated $25.6M sold.

Based on aggregated 13F filings for Q3 2020.